Weiping Zou

Department of Surgery, University of Michigan

Research Area

Biography

Weiping Zou has not added Biography.
If you are Weiping Zou and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 15	2019

Other Publications

Article	Year
Regulatory T-cell compartmentalization and trafficking. Blood\| PubMed ID: 16537800	2006
Regulatory T cells, tumour immunity and immunotherapy. Nature reviews. Immunology\| PubMed ID: 16557261	2006
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. The Journal of experimental medicine\| PubMed ID: 16606666	2006
Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16785496	2006
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. American journal of physiology. Cell physiology\| PubMed ID: 16943240	2007
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17513719	2007
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer research\| PubMed ID: 17671219	2007
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer research\| PubMed ID: 17875732	2007
Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrobial agents and chemotherapy\| PubMed ID: 17923491	2007
Inhibitory B7-family molecules in the tumour microenvironment. Nature reviews. Immunology\| PubMed ID: 18500231	2008
Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer research\| PubMed ID: 18593946	2008
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18802076	2008
Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18941172	2008
Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood\| PubMed ID: 19289853	2009
FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer research\| PubMed ID: 19383912	2009
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood\| PubMed ID: 19470694	2009
Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer research\| PubMed ID: 19826049	2009
Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. Mathematical biosciences and engineering : MBE\| PubMed ID: 19835428	2009
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19917689	2009
Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology\| PubMed ID: 19931266	2010
T(H)17 cells in tumour immunity and immunotherapy. Nature reviews. Immunology\| PubMed ID: 20336152	2010
Prognostic significance of regulatory T cells in tumor. International journal of cancer\| PubMed ID: 20473951	2010
A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20810991	2010
Th17 cells in cancer: help or hindrance? Carcinogenesis\| PubMed ID: 21304053	2011
T lymphocytes to IDO+ cells: check. Blood\| PubMed ID: 21330479	2011
IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21357259	2011
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. International journal of cancer. Journal international du cancer\| PubMed ID: 21480217	2012
Antigen-presenting cell (APC) subsets in ovarian cancer. International reviews of immunology\| PubMed ID: 21557638	2011
Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes & development\| PubMed ID: 21764854	2011
Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer immunology, immunotherapy : CII\| PubMed ID: 21918895	2011
Deciphering the role of Th17 cells in human disease. Trends in immunology\| PubMed ID: 21958759	2011
Human TH17 cells are long-lived effector memory cells. Science translational medicine\| PubMed ID: 21998407	2011
Bone marrow and the control of immunity. Cellular & molecular immunology\| PubMed ID: 22020068	2012
Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer research\| PubMed ID: 22123924	2012
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. Journal of translational medicine\| PubMed ID: 22176654	2011
The B7 homologues and their receptors in hematologic malignancies. European journal of haematology\| PubMed ID: 22372959	2012
Regulatory T cells in human ovarian cancer. Journal of oncology\| PubMed ID: 22481922	2012
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology\| PubMed ID: 22720236	2012
Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology\| PubMed ID: 22754771	2012
Nine lives for TH9s? Nature medicine\| PubMed ID: 22869182	2012
Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer investigation\| PubMed ID: 23072563	2012
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Current opinion in immunology\| PubMed ID: 23298609	2013
Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 23377667	2013
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 23690607	2013
Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity\| PubMed ID: 24012420	2013
TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PloS one\| PubMed ID: 24058595	2013
Synbindin in Extracellular Signal-Regulated Protein Kinase Spatial Regulation and Gastric Cancer Aggressiveness. Journal of the National Cancer Institute\| PubMed ID: 24104608	2013
T cells and costimulation in cancer. Cancer journal (Sudbury, Mass.)\| PubMed ID: 24270346	2013
OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer. Gut\| PubMed ID: 24717932	2015
IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity\| PubMed ID: 24816405	2014
TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24987055	2014
ArhGAP30 promotes p53 acetylation and function in colorectal cancer. Nature communications\| PubMed ID: 25156493	2014
MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Scientific reports\| PubMed ID: 25174450	2014
Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology\| PubMed ID: 25181692	2014
Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer research\| PubMed ID: 25277524	2014
MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway. Theranostics\| PubMed ID: 25285168	2014
Classification of current anticancer immunotherapies. Oncotarget\| PubMed ID: 25537519	2014
Myeloid cells in hepatocellular carcinoma. Hepatology (Baltimore, Md.)\| PubMed ID: 25914264	2015
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Cancer immunology research\| PubMed ID: 26025381	2015
Consensus nomenclature for CD8+ T cell phenotypes in cancer. Oncoimmunology\| PubMed ID: 26137416	2015
Dendritic cells are stressed out in tumor. Cell research\| PubMed ID: 26227962	2015
Chemokines and cellular plasticity of ovarian cancer stem cells. Oncoscience\| PubMed ID: 26328269	2015
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature\| PubMed ID: 26503055	2015
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nature immunology\| PubMed ID: 26523864	2016
PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer research\| PubMed ID: 26567139	2016
Biological and pathological activities of interleukin-22. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 26923718	2016
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science translational medicine\| PubMed ID: 26936508	2016
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology\| PubMed ID: 27057439	2016
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. Cell\| PubMed ID: 27133165	2016
LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. Cancer discovery\| PubMed ID: 27147598	2016
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. Cancer research\| PubMed ID: 27197152	2016
Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling. Oncoimmunology\| PubMed ID: 27622053	2016
Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma. Oncoimmunology\| PubMed ID: 27622054	2016
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology\| PubMed ID: 28123897	2016
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment. Cancer research\| PubMed ID: 28249897	2017
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature reviews. Immunology\| PubMed ID: 28555670	2017
ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nature cell biology\| PubMed ID: 28737768	2017
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell\| PubMed ID: 28753429	2017
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nature immunology\| PubMed ID: 29083399	2017
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. The Journal of clinical investigation\| PubMed ID: 29106384	2017
Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity. Science immunology\| PubMed ID: 29150439	2017
Phenotype and tissue distribution of CD28H immune cell subsets. Oncoimmunology\| PubMed ID: 29209568	2017
The Role of Tumor Microenvironment in Cancer Immunotherapy. Advances in experimental medicine and biology\| PubMed ID: 29275464	2017
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. The Journal of clinical investigation\| PubMed ID: 29337305	2018
miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer. Cancer research\| PubMed ID: 29374066	2018
Mechanistic insights into cancer immunity and immunotherapy. Cellular & molecular immunology\| PubMed ID: 29572549	2018
Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature medicine\| PubMed ID: 29686425	2018
Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness . Cancer research\| PubMed ID: 29769201	2018
Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29802127	2018
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell metabolism\| PubMed ID: 29805099	2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. Cell\| PubMed ID: 29906450	2018
Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy. Gynecologic oncology\| PubMed ID: 30243508	2018
Spatial and phenotypic immune profiling of metastatic colon cancer. JCI insight\| PubMed ID: 30429368	2018
Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28. The Journal of surgical research\| PubMed ID: 30463776	2018
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease. Journal of Crohn's & colitis\| PubMed ID: 30715262	2019
CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. Nature\| PubMed ID: 31043744	2019
RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment. Cancer immunology research\| PubMed ID: 31064778	2019
Immunotherapy in Ovarian Cancer. Surgical oncology clinics of North America\| PubMed ID: 31079799	2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Cancer research\| PubMed ID: 31101760	2019
Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells. Annals of surgical oncology\| PubMed ID: 31250346	2019